Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Prelude Therapeutics Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 70
- +10 vs. Q2 2024
- Shares held
- 35.8M
- +2.91M (+8.8%) vs. Q2 2024
- Total value
- $74.0M
- −$51.1M (−40.9%) vs. Q2 2024
- New holders
- 17
- 20 more added
- Sold out
- 7
- 20 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $264.3M |
| Q1 2026 | 55 | $105.2M |
| Q4 2025 | 48 | $82.6M |
| Q3 2025 | 47 | $39.1M |
| Q2 2025 | 50 | $22.0M |
| Q1 2025 | 59 | $23.3M |
| Q4 2024 | 62 | $41.0M |
| Q3 2024 | 70 | $74.0M |
| Q2 2024 | 61 | $129.2M |
| Q1 2024 | 58 | $162.1M |
| Q4 2023 | 56 | $148.3M |
| Q3 2023 | 60 | $113.1M |
| Q2 2023 | 55 | $176.2M |
| Q1 2023 | 55 | $179.6M |
| Q4 2022 | 60 | $188.3M |
| Q3 2022 | 53 | $210.3M |
| Q2 2022 | 62 | $170.9M |
| Q1 2022 | 68 | $235.4M |
| Q4 2021 | 75 | $437.6M |
| Q3 2021 | 61 | $1.12B |
| Q2 2021 | 57 | $986.6M |
| Q1 2021 | 60 | $1.41B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Prelude Therapeutics Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 10,909,256 | $22.6M | 0.41% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 10,123,824 | $21.0M | 0.22% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 3,766,120 | $7.80M | 0.12% | −366,880−8.9% | Reduced |
| Boxer Capital, LLC | 1,708,187 | $3.54M | 0.17% | −860,100−33.5% | Reduced |
| Price T Rowe Associates Inc | 1,097,599 | $2.27M | 0.00% | +206,301+23.1% | Added |
| BlackRock, Inc. | 1,058,316 | $2.19M | 0.00% | +1,058,316 | New |
| Vanguard Group Inc | 1,021,770 | $2.12M | 0.00% | +11,205+1.1% | Added |
| ExodusPoint Capital Management, LP | 921,621 | $1.91M | 0.02% | +921,621 | New |
| Avidity Partners Management LP | 890,000 | $1.84M | 0.09% | +890,000 | New |
| Massachusetts Financial Services Co | 549,530 | $1.14M | 0.00% | +27,155+5.2% | Added |
| Geode Capital Management, LLC | 391,716 | $810.9K | 0.00% | +29,765+8.2% | Added |
| Marshall Wace, LLP | 359,137 | $743.4K | 0.00% | +359,137 | New |
| Morgan Stanley | 323,689 | $670.0K | 0.00% | +36,335+12.6% | Added |
| State Street Corp | 286,046 | $592.1K | 0.00% | +74,300+35.1% | Added |
| T. Rowe Price Investment Management, Inc. | 281,583 | $583.0K | 0.00% | +281,583 | New |
| Renaissance Technologies LLC | 196,900 | $407.6K | 0.00% | −9,700−4.7% | Reduced |
| Bridgeway Capital Management, LLC | 176,100 | $364.5K | 0.01% | +52,500+42.5% | Added |
| Jacobs Levy Equity Management, Inc | 174,979 | $362.2K | 0.00% | +157,218+885.2% | Added |
| TD Asset Management Inc | 160,652 | $340.6K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 160,524 | $332.3K | 0.00% | +160,524 | New |
| Charles Schwab Investment Management Inc | 133,249 | $275.8K | 0.00% | +5,216+4.1% | Added |
| Northern Trust Corp | 106,377 | $220.2K | 0.00% | −18,309−14.7% | Reduced |
| Goldman Sachs Group Inc | 95,161 | $197.0K | 0.00% | +20,238+27.0% | Added |
| Walleye Capital LLC | 83,175 | $172.2K | 0.00% | +67,946+446.2% | Added |
| Acadian Asset Management LLC | 74,143 | $152.0K | 0.00% | +52,033+235.3% | Added |
| Manufacturers Life Insurance Company, The | 70,045 | $145.0K | 0.00% | 00.0% | Unchanged |
| Exchange Traded Concepts, LLC | 64,409 | $133.3K | 0.00% | +15,682+32.2% | Added |
| Two Sigma Investments, LP | 56,933 | $117.9K | 0.00% | +13,798+32.0% | Added |
| XTX Topco Ltd | 48,239 | $99.9K | 0.01% | +48,239 | New |
| Two Sigma Advisers, LP | 47,900 | $99.2K | 0.00% | −3,000−5.9% | Reduced |
| Cubist Systematic Strategies, LLC | 40,102 | $83.0K | 0.00% | +40,102 | New |
| Cerity Partners LLC | 32,875 | $68.1K | 0.00% | +32,875 | New |
| Dimensional Fund Advisors LP | 29,082 | $60.3K | 0.00% | +80.0% | Added |
| Bank of New York Mellon Corp | 28,613 | $59.2K | 0.00% | −7,663−21.1% | Reduced |
| Barclays PLC | 27,165 | $56.2K | 0.00% | +12,564+86.0% | Added |
| Bank of America Corp | 24,944 | $51.6K | 0.00% | −9,334−27.2% | Reduced |
| HSBC Holdings PLC | 20,772 | $43.8K | 0.00% | −4,133−16.6% | Reduced |
| Sherbrooke Park Advisers LLC | 20,048 | $41.5K | 0.01% | +20,048 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 17,293 | $35.8K | 0.00% | +4,948+40.1% | Added |
| Nuveen Asset Management, LLC | 16,797 | $34.8K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 15,534 | $32.2K | 0.00% | +15,534 | New |
| Citadel Advisors LLC | 15,225 | $31.5K | 0.00% | −16,163−51.5% | Reduced |
| Deutsche Bank AG | 14,618 | $30.3K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 12,004 | $24.8K | 0.00% | −9,561−44.3% | Reduced |
| Verition Fund Management LLC | 11,295 | $23.4K | 0.00% | +11,295 | New |
| Jane Street Group, LLC | 10,361 | $21.4K | 0.00% | −2,587−20.0% | Reduced |
| Citigroup Inc | 9,655 | $20.0K | 0.00% | +6,641+220.3% | Added |
| Simplex Trading, LLC | 9,332 | $19.0K | 0.00% | +9,332 | New |
| FMR LLC | 7,618 | $15.8K | 0.00% | −1,957−20.4% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 7,271 | $15.1K | 0.00% | −864−10.6% | Reduced |
| Corebridge Financial, Inc. | 7,049 | $14.6K | 0.00% | −43−0.6% | Reduced |
| UBS Group AG | 7,016 | $14.5K | 0.00% | −3,918−35.8% | Reduced |
| Wells Fargo & Company | 6,053 | $12.5K | 0.00% | +261+4.5% | Added |
| JPMorgan Chase & Co | 5,966 | $12.3K | 0.00% | +106+1.8% | Added |
| Tower Research Capital LLC (TRC) | 5,302 | $11.0K | 0.00% | −1,762−24.9% | Reduced |
| Point72 (DIFC) Ltd | 5,206 | $10.8K | 0.00% | +5,206 | New |
| New York State Common Retirement Fund | 3,622 | $7.50K | 0.00% | −15,500−81.1% | Reduced |
| Royal Bank of Canada | 2,855 | $6.00K | 0.00% | −84−2.9% | Reduced |
| Legal & General Group Plc | 962 | $1.99K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 955 | $1.98K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 819 | $1.70K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 500 | $1.03K | 0.00% | +500 | New |
| Amalgamated Bank | 334 | $1.00K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 76 | $157 | 0.00% | −1,405−94.9% | Reduced |
| The PNC Financial Services Group, Inc. | 64 | $132 | 0.00% | 00.0% | Unchanged |
| HighMark Wealth Management LLC | 50 | $104 | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 42 | $87 | 0.00% | +42 | New |
| SRS Capital Advisors, Inc. | 19 | $40 | 0.00% | 00.0% | Unchanged |
| Capital Performance Advisors LLP | 8 | $17 | 0.00% | +8 | New |
| CWM, LLC | 10 | $0 | 0.00% | −12−54.5% | Reduced |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −320,394−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −35,283−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −18,839−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −3,126−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −2,100−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |